CONDUIT PHARMACEUTICALS INC
CDTLatest QuantConomy context for CDT: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
7
Asset profile
CONDUIT PHARMACEUTICALS INC
QuantConomy has a structured record for CDT. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- CDT
- Name
- CONDUIT PHARMACEUTICALS INC
- Coverage
- 3 market/data records
- Sources
- alpaca fmp alphavantage sec nasdaq axs
Latest signal rows
Recent signals for CDT
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| material agreement | bullish | 85 | Jul 7, 09:25 PM | CDT filed 8-K: Material Definitive Agreement, Direct Financial Obligation - 2 material events - [very strong bullish signal] |
| material agreement | bullish | 90 | Jun 16, 09:10 PM | CDT filed 8-K: Material Definitive Agreement, Direct Financial Obligation, Unregistered Sales of Equity - 4 material events - [very strong bullish signal] |
| delisting | very bearish | 85 | May 28, 08:35 PM | CDT filed 8-K: Delisting Notice, Regulation FD Disclosure - 2 material events - [very strong very bearish signal] |
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| CDT | NASDAQ | alpaca | Conduit Pharmaceuticals Inc. Common Stock |
| CDT | NASDAQ | fmp | CDT Equity Inc. |
| CDT | NASDAQ | alphavantage | CDT Equity Inc |
Recent insider transactions
Buys, last 90d
0
Sells, last 90d
1
Rows
7
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Taylor Mark Andrew | Insider | sale | 5,000 | $0.71 | $3,526 | 5 on EDGAR |
| — | Olsen Ulrik K | Insider | — | — | — | — | 3 on EDGAR |
| Mar 24, 2026 | Regan Andrew | Chief Executive Officer | grant | 147,401 | — | — | 4 on EDGAR |
| Feb 19, 2026 | Taylor Mark Andrew | Insider | other | 46,902 | $0.00 | $0 | 4 on EDGAR |
| Feb 19, 2026 | Farley Chele Chiavacci | Insider | grant | 10,553 | $1.04 | $10,975 | 4 on EDGAR |
| — | Taylor Mark Andrew | Insider | — | — | — | — | 3 on EDGAR |
| Dec 8, 2025 | Regan Andrew | Chief Executive Officer | grant | 224,800 | $1.79 | $402,392 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Get the data
Query CDT context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access